Deep Track Capital »

Biohaven shares owned by Deep Track Capital

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.6M 500k 11.29

More positions owned by Deep Track Capital

Spdr Series Trust State Street Spd Put Option (XBI)
Immunovant (IMVT)
Guardant Health (GH)
Structure Therapeutics Sponsored Ads (GPCR)
Tarsus Pharmaceuticals (TARS)
Dynavax Technologies Corp Com New (DVAX)
Cytokinetics Com New (CYTK)
Axsome Therapeutics (AXSM)
Apellis Pharmaceuticals (APLS)
Vaxcyte (PCVX)
Maze Therapeatics (MAZE)
Vera Therapeutics Cl A (VERA)
BioMarin Pharmaceutical (BMRN)
Ionis Pharmaceuticals (IONS)
Nurix Therapeutics (NRIX)

View all positions for Deep Track Capital

Top funds holding Biohaven

Suvretta Capital Management
Stifel Financial
BlackRock
Henderson Group
Infinitum Asset Management
State Street Corporation
TCG Crossover Management
Vanguard Group
FMR
Geode Capital Management
Susquehanna International
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Caption Management
Schonfeld Strategic Advisors

View all funds holding Biohaven